Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma.
Fares S, Wehrle CJ, Hong H, Sun K, Jiao C, Zhang M, Gross A, Allkushi E, Uysal M, Kamath S, Ma WW, Modaresi Esfeh J, Linganna MW, Khalil M, Pita A, Kim J, Walsh RM, Miller C, Hashimoto K, Schlegel A, Kwon DCH, Aucejo F.
Fares S, et al. Among authors: hashimoto k.
Cancers (Basel). 2024 Apr 10;16(8):1453. doi: 10.3390/cancers16081453.
Cancers (Basel). 2024.
PMID: 38672535
Free PMC article.
Review.
Circulating tumor DNA (ctDNA), genomic glycosylation, and even totally non-invasive salivary metabolomics and/or micro-RNAS demonstrate great promise for early detection and long-term surveillance, but still require large-scale prospective validation to definitively valida …
Circulating tumor DNA (ctDNA), genomic glycosylation, and even totally non-invasive salivary metabolomics and/or micro-RNAS demonstrate grea …